Zhongyuan Union Cell & Gene Engineering Corp., Ltd (SHSE:600645) announced a private placement of equity shares for the gross proceeds of not more than CNY 500,000,000 on January 4, 2018. The transaction will include not more than ten investors including returning investor Tianjin Development Zone Deyuan Investment Development Co., Ltd. for not more than CNY 250,000,000. The shares issued to Tianjin Development Zone Deyuan Investment Development Co., Ltd. cannot be transferred within 36 months from the issuance closing date, and the shares the other investors subscribe to cannot be transferred within 12 months from the issuance closing date. The transaction has been approved in the 9th meeting of the its 9th directorate, and is subject to the approvals of its shareholders, the China Securities Regulatory Commission, and the Committee on Foreign Investment in the United States.The company will pay CNY 40,000,000 as relevant fees for this transaction.